文献速递慢性肾脏病遗传性与小管间质肾病肾小球疾病

单基因肾病中拷贝数变异分析的重要性

The Importance of Copy Number Variant Analysis in Patients with Monogenic Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2024-06-22

该研究在2432例于2014年至2022年间接受基因检测的肾病患者中,回顾性分析拷贝数变异(CNV)的诊断价值。完全诊断队列的诊断率至少为23%,仅基于CNV的诊断率为2.4%,CNV分析总体贡献为10.5%,在先天性肾脏和尿路畸形(CAKUT)及年轻慢性肾脏病中影响最大。研究支持将CNV分析常规纳入肾病基因检测。

要点

  • 完全诊断队列的诊断率至少为23%,仅CNV贡献2.4%。
  • CNV分析总体贡献为10.5%,在CAKUT和年轻CKD中最高。
  • 基于外显子的CNV检测可减少额外诊断检测需求。

核心结论

  • CNV分析在肾病患者基因检测中具有显著诊断价值,应常规纳入。

研究设计与样本

  • 回顾性研究纳入2014年至2022年5月于乌得勒支大学医学中心接受基因检测的2432例肾病患者,结合既往SNV和CNV结果与新回顾性CNV分析。

主要发现

  • 完全诊断队列的诊断率至少为23%。
  • 仅基于CNV的诊断率为2.4%。
  • CNV分析总体贡献为10.5%,在不同疾病亚类间有差异,CAKUT和年轻CKD影响最高。
  • 发现一个复杂结构变异,可能为COL4A4奠基者变异。
  • 小比例病例报告了与肾病无关的额外发现。

关键数值与推荐

  • 诊断率报告考虑ACMG分类及基因型是否实际导致疾病。
  • CNV分析总体贡献定义为需要CNV分析的阳性基因检测比例。

临床怎么用

  • 对肾病患者基因检测应常规包含CNV分析,尤其CAKUT和年轻CKD患者。
  • 基于外显子的CNV检测可提高效率并减少额外检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Genetic testing can reveal monogenic causes of kidney diseases, offering diagnostic, therapeutic, and prognostic benefits. Although single nucleotide variants (SNVs) and copy number variants (CNVs) can result in kidney disease, CNV analysis is not always included in genetic testing. METHODS: We investigated the diagnostic value of CNV analysis in 2432 patients with kidney disease genetically tested at the University Medical Centre Utrecht between 2014 and May 2022. We combined previous diagnostic testing results, encompassing SNVs and CNVs, with newly acquired results based on retrospective CNV analysis. The reported yield considers both the American College of Medical Genetics and Genomics (ACMG) classification and whether the genotype actually results in disease. RESULTS: We report a diagnostic yield of at least 23% for our complete diagnostic cohort. The total diagnostic yield based solely on CNVs was 2.4%. The overall contribution of CNV analysis, defined as the proportion of positive genetic tests requiring CNV analysis, was 10.5% and varied among different disease subcategories, with the highest impact seen in congenital anomalies of the kidney and urinary tract (CAKUT) and chronic kidney disease at a young age. We highlight the efficiency of exome-based CNV calling, which reduces the need for additional diagnostic tests. Furthermore, a complex structural variant, likely a COL4A4 founder variant, was identified. Additional findings unrelated to kidney diseases were reported in a small percentage of cases. CONCLUSION: In summary, this study demonstrates the substantial diagnostic value of CNV analysis, providing insights into its contribution to the diagnostic yield and advocating for its routine inclusion in genetic testing of patients with kidney disease.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Claus LR, Ernst RF, Elferink MG, et al. The Importance of Copy Number Variant Analysis in Patients with Monogenic Kidney Disease. Kidney Int Rep. 2024. PMID: 39291214. doi:10.1016/j.ekir.2024.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。